Related references
Note: Only part of the references are listed.Global Tuberculosis Report 2020-Reflections on the Global TB burden, treatment and prevention efforts
Jeremiah Chakaya et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Advances in host-based screening for compounds with intracellular anti-mycobacterial activity
Neeraja Subhash et al.
CELLULAR MICROBIOLOGY (2021)
Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms
Zsuzsa Baranyai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
THP-1 and Dictyostelium Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds
Adrian Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides
Edit Pari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
WHO global progress report on tuberculosis elimination (vol 8, pg 19, 2020)
E. Harding
LANCET RESPIRATORY MEDICINE (2020)
Disorder-to-helix conformational conversion of the human immunomodulatory peptide LL-37 induced by antiinflammatory drugs, food dyes and some metabolites
Ferenc Zsila et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Sergey Borisov et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
The Immune Escape Mechanisms of Mycobacterium Tuberculosis
Weijie Zhai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Surface Layer Modification of Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate
Kata Horvati et al.
BIOCONJUGATE CHEMISTRY (2018)
Secondary structure of cell-penetrating peptides during interaction with fungal cells
Zifan Gong et al.
PROTEIN SCIENCE (2018)
Fluorescent Mycobacterium tuberculosis reporters: illuminating host-pathogen interactions
Nathan J. MacGilvary et al.
PATHOGENS AND DISEASE (2018)
The zebrafish model of tuberculosis - no lungs needed
Ghada Bouz et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2018)
Hemin and bile pigments are the secondary structure regulators of intrinsically disordered antimicrobial peptides
Ferenc Zsila et al.
CHIRALITY (2018)
In Vitro Models to Study Human Lung Development, Disease and Homeostasis
Alyssa J. Miller et al.
PHYSIOLOGY (2017)
Experimental study of tuberculosis: From animal models to complex cell systems and organoids
Kaori L. Fonseca et al.
PLOS PATHOGENS (2017)
New concepts in understanding latent tuberculosis
Claire E. Dodd et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
Ameeruddin Nusrath Unissa et al.
INFECTION GENETICS AND EVOLUTION (2016)
C-type lectin receptors in tuberculosis: what we know
Surabhi Goyal et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2016)
Antibacterial drug discovery in the resistance era
Eric D. Brown et al.
NATURE (2016)
PharmGKB summary: isoniazid pathway, pharmacokinetics
Daniel J. Klein et al.
PHARMACOGENETICS AND GENOMICS (2016)
A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation
Andreas Kupz et al.
PLOS ONE (2016)
Mouse and Guinea Pig Models of Tuberculosis
Ian M. Orme et al.
MICROBIOLOGY SPECTRUM (2016)
Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach
Aurelien Chollet et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models
Kata Horvati et al.
TUBERCULOSIS (2015)
Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium's Metabolism Is Constrained by the Intracellular Environment
Brian C. VanderVen et al.
PLOS PATHOGENS (2015)
Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion
Mark Schiebler et al.
EMBO MOLECULAR MEDICINE (2015)
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
Rasheena Edmondson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Nanoparticle Encapsulated Lipopeptide Conjugate of Antitubercular Drug Isoniazid: In Vitro Intracellular Activity and in Vivo Efficacy in a Guinea Pig Model of Tuberculosis
Kata Horvati et al.
BIOCONJUGATE CHEMISTRY (2014)
Fit for consumption: zebrafish as a model for tuberculosis
Mark R. Cronan et al.
DISEASE MODELS & MECHANISMS (2014)
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Philana Ling Lin et al.
NATURE MEDICINE (2014)
Modeling Tuberculosis in Nonhuman Primates
Charles A. Scanga et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
Sarah A. Stanley et al.
PLOS PATHOGENS (2014)
Coupling reporter expression to respiration detects active as well as dormant mycobacteria in vitro and in mouse tissues
Subash Chand Verma et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2014)
Integration of Chemical and RNAi Multiparametric Profiles Identifies Triggers of Intracellular Mycobacterial Killing
Varadharajan Sundaramurthy et al.
CELL HOST & MICROBE (2013)
Oral Bioavailability of Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide in a 4-Drug Fixed-Dose Combination Compared With the Separate Formulations in Healthy Chinese Male Volunteers
Jian Xu et al.
CLINICAL THERAPEUTICS (2013)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Kevin Pethe et al.
NATURE MEDICINE (2013)
Spontaneous Latency in a Rabbit Model of Pulmonary Tuberculosis
Selvakumar Subbian et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
An Isoniazid Analogue Promotes Mycobacterium tuberculosis-Nanoparticle Interactions and Enhances Bacterial Killing by Macrophages
Tatiany J. de Faria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Peptides and peptide conjugates: therapeutics on the upward path
Verena M. Ahrens et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Insights into tuberculosis from the zebrafish model
Russell D. Berg et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Establishment and characterization of primary lung cancer cell lines from Chinese population
Chao Zheng et al.
ACTA PHARMACOLOGICA SINICA (2011)
Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
Seok-Yong Eum et al.
CHEST (2010)
Peptide conjugates of therapeutically used antitubercular isoniazid - design, synthesis and antimycobacterial effect
Kata Horvati et al.
JOURNAL OF PEPTIDE SCIENCE (2009)
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Clifton E. Barry et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model
Anup K. Kesavan et al.
TUBERCULOSIS (2009)
Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice
Rahul Kumar Verma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro
Tathagata Dutta et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
New insight into the mechanism of action of and resistance to isoniazid:: Interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP
Argyrides Argyrou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Mechanisms of action of isoniazid
Graham S. Timmins et al.
MOLECULAR MICROBIOLOGY (2006)
Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles
Jarmila Vinsova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients
H McIlleron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mouse and guinea pig models for testing new tuberculosis vaccines
IM Orme
TUBERCULOSIS (2005)
Regulated portals of entry into the cell
SD Conner et al.
NATURE (2003)
Share Paper
